Investors Buy Large Volume of Tilray Call Options (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY - Get Free Report) was the target of unusually large options trading on Wednesday. Stock investors bought 67,207 call options on the stock. This represents an increase of approximately 89% compared to the average daily volume of 35,652 call options.

Insiders Place Their Bets

In other Tilray news, CFO Carl A. Merton purchased 26,000 shares of the stock in a transaction on Friday, November 15th. The stock was acquired at an average price of $1.36 per share, with a total value of $35,360.00. Following the transaction, the chief financial officer now directly owns 26,000 shares of the company's stock, valued at approximately $35,360. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.87% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its stake in shares of Tilray by 3.5% in the 1st quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company's stock worth $8,707,000 after acquiring an additional 117,891 shares during the period. Bank of Montreal Can boosted its holdings in Tilray by 0.3% in the 3rd quarter. Bank of Montreal Can now owns 2,176,506 shares of the company's stock worth $3,787,000 after acquiring an additional 7,406 shares during the period. State Street Corp raised its holdings in Tilray by 4.7% in the third quarter. State Street Corp now owns 1,961,338 shares of the company's stock valued at $3,452,000 after acquiring an additional 88,079 shares in the last quarter. BNP Paribas Financial Markets raised its position in shares of Tilray by 1,314.1% during the 3rd quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company's stock valued at $3,202,000 after acquiring an additional 1,690,827 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Tilray by 6.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,677,899 shares of the company's stock worth $2,953,000 after acquiring an additional 107,530 shares during the period. Institutional investors and hedge funds own 9.35% of the company's stock.

Tilray Stock Performance

Shares of Tilray stock traded down $0.02 during trading on Wednesday, hitting $1.26. 38,783,906 shares of the company's stock were exchanged, compared to its average volume of 25,690,229. Tilray has a 52-week low of $1.22 and a 52-week high of $2.97. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.57 and a current ratio of 2.47. The stock has a market capitalization of $1.14 billion, a price-to-earnings ratio of -4.54 and a beta of 2.09. The business has a 50-day simple moving average of $1.51 and a 200-day simple moving average of $1.69.

Tilray (NASDAQ:TLRY - Get Free Report) last posted its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) EPS for the quarter, hitting the consensus estimate of ($0.04). The company had revenue of $200.00 million during the quarter, compared to analyst estimates of $218.70 million. Tilray had a negative return on equity of 2.00% and a negative net margin of 26.79%. Tilray's quarterly revenue was up 13.0% on a year-over-year basis. During the same period in the previous year, the business earned ($0.10) EPS. On average, research analysts forecast that Tilray will post -0.14 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Roth Mkm dropped their target price on shares of Tilray from $2.00 to $1.75 and set a "neutral" rating for the company in a research report on Friday, October 11th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.